U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: September 2-8 , 2018
  1. FDA Meetings, Conferences and Workshops

Public Calendar: September 2-8 , 2018

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 09/04/2018
Location: Silver Spring, MD
Subject: Facilitating Price Competition and Innovation in the Biological Products Marketplace
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Industry, government, stakeholders, media, and registered guests

Event Date: 09/05/2018
Location: Washington, DC
Subject: Medical Device Innovation Consortium Annual Public Forum
FDA Participant/Group: JEFFREY SHUREN; CARLYLE MCWILLIAMS;
Non FDA Participant/Group: Government, media, industry, academia, and other invited guests

Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/03/2018
Location: Dublin, Ireland
Subject: World Health Organization 18th International Conference of Drug Regulatory Authorities
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 09/06/2018
Location: Washington, DC
Subject: Medical Device Innovation Consortium: Board of Directors Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Lowell Schiller, J.D., Acting Chief Counsel

No Significant Event